GE HealthCare Technologies Inc. $GEHC Stock: Barrow Hanley Mewhinney & Strauss LLC Boosts Position

GE HealthCare Technologies logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Barrow Hanley increased its GE HealthCare stake by 2.3%, adding 314,050 shares to bring its holdings to 13.77 million shares, worth about $900 million. The stock is the firm’s second-largest position.
  • GE HealthCare beat quarterly earnings and revenue expectations, reporting EPS of $1.34 and revenue of $5.51 billion; revenue grew 7.2% year over year. Analysts’ consensus rating is “Moderate Buy,” with an average price target of $82.52.
  • The company raised its quarterly dividend from $0.035 to $0.04 per share, equivalent to a 0.2% annualized yield.
  • Five stocks to consider instead of GE HealthCare Technologies.

Barrow Hanley Mewhinney & Strauss LLC increased its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 2.3% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 13,769,864 shares of the company's stock after buying an additional 314,050 shares during the period. GE HealthCare Technologies comprises approximately 2.9% of Barrow Hanley Mewhinney & Strauss LLC's holdings, making the stock its 2nd biggest position. Barrow Hanley Mewhinney & Strauss LLC owned 3.05% of GE HealthCare Technologies worth $900,136,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. Ritholtz Wealth Management purchased a new position in GE HealthCare Technologies in the third quarter worth about $1,285,000. Northside Capital Management LLC raised its holdings in GE HealthCare Technologies by 26.5% in the 2nd quarter. Northside Capital Management LLC now owns 241,923 shares of the company's stock worth $15,485,000 after purchasing an additional 50,634 shares during the period. Hsbc Holdings PLC lifted its position in GE HealthCare Technologies by 22.8% during the second quarter. Hsbc Holdings PLC now owns 1,004,490 shares of the company's stock valued at $64,217,000 after purchasing an additional 186,800 shares in the last quarter. TD Waterhouse Canada Inc. lifted its position in GE HealthCare Technologies by 5.1% during the third quarter. TD Waterhouse Canada Inc. now owns 608,890 shares of the company's stock valued at $39,015,000 after purchasing an additional 29,752 shares in the last quarter. Finally, Trian Fund Management L.P. grew its holdings in GE HealthCare Technologies by 76,194.4% during the second quarter. Trian Fund Management L.P. now owns 3,085,344 shares of the company's stock valued at $197,493,000 after purchasing an additional 3,081,300 shares during the period. 82.06% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

GEHC has been the topic of several research analyst reports. Wall Street Zen raised shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating in a report on Saturday, October 31st. Citigroup raised their target price on shares of GE HealthCare Technologies from $71.00 to $79.00 and gave the company a "neutral" rating in a research note on Thursday, October 29th. Needham & Company LLC restated a "buy" rating and set a $93.00 price objective on shares of GE HealthCare Technologies in a research report on Monday, October 5th. Oppenheimer reaffirmed an "outperform" rating on shares of GE HealthCare Technologies in a report on Thursday, July 30th. Finally, Wolfe Research initiated coverage on GE HealthCare Technologies in a research report on Tuesday, October 20th. They issued a "peer perform" rating on the stock. Twelve research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $82.52.

View Our Latest Analysis on GE HealthCare Technologies

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $80.54 on Friday. GE HealthCare Technologies Inc. has a 52 week low of $58.75 and a 52 week high of $89.77. The business's 50 day moving average price is $72.19 and its 200 day moving average price is $70.19. The company has a quick ratio of 1.01, a current ratio of 1.30 and a debt-to-equity ratio of 0.86. The firm has a market cap of $36.42 billion, a P/E ratio of 16.99, a P/E/G ratio of 2.09 and a beta of 0.65.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its quarterly earnings results on Wednesday, October 28th. The company reported $1.34 earnings per share for the quarter, beating analysts' consensus estimates of $1.20 by $0.14. The business had revenue of $5.51 billion during the quarter, compared to analysts' expectations of $5.35 billion. GE HealthCare Technologies had a net margin of 9.96% and a return on equity of 20.45%. The business's revenue for the quarter was up 7.2% on a year-over-year basis. During the same period last year, the business earned $1.07 earnings per share. On average, sell-side analysts expect that GE HealthCare Technologies Inc. will post 5.02 earnings per share for the current year.

GE HealthCare Technologies Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, November 13th. Stockholders of record on Friday, October 23rd were issued a $0.04 dividend. This represents a $0.16 annualized dividend and a dividend yield of 0.2%. The ex-dividend date was Friday, October 23rd. This is a positive change from GE HealthCare Technologies's previous quarterly dividend of $0.0350. GE HealthCare Technologies's dividend payout ratio (DPR) is currently 3.38%.

GE HealthCare Technologies Company Profile

(Free Report)

GE HealthCare Technologies Inc. is a global medical technology company that develops and provides equipment, software and services for healthcare providers. Its offerings support medical imaging, diagnosis, patient monitoring and treatment across a range of clinical settings. The company's products include magnetic resonance imaging, computed tomography, molecular imaging and ultrasound systems, as well as patient monitoring and care solutions. Its Pharmaceutical Diagnostics business supplies contrast agents and radiopharmaceuticals used in medical imaging.

Further Reading

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in GE HealthCare Technologies Right Now?

Before you consider GE HealthCare Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.

While GE HealthCare Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines